Author

Laura Kaiser

University of CologneORCID 0000-0002-3212-576XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Julie GeorgeiD· 2 shared Agnieszka Rumińska· 1 shared Alejandra G. SerranoiD· 1 shared Alexa Halliday· 1 shared Alexander QuaasiD· 1 shared Angelika Beate RiemeriD· 1 shared Anna SchöllhorniD· 1 shared Ariadne Androulidaki· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Julie GeorgeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyJournal of Thoracic OncologyPeer-reviewedApr 20, 2026

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

Catherine Allison Stewart, Kavya Ramkumar, Runsheng Wang…·Carl Michael Gay

This study identifies YAP1-positive cells in relapsed SCLC that exhibit drug tolerance and transition from SCLC to LCNEC-like features, losing some targets but gaining others.

8 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 2, 2026

A targetable dependency on nonsense-mediated decay for proteostasis and immune control in small cell lung cancer

Lucia Torres Fernández, Volker Boehm, Joel Kaufmann…·Julie George

This study identifies NMD inhibition as a therapeutic strategy for SCLC by enhancing immunogenicity and improving immunotherapy efficacy through increased neoantigen presentation.

DOI 10.64898/2026.03.31.715503

humanbulk RNA-seq

𝕏 PostBluesky